You are here: Industry Insights > Roche

News List

FDA extends review time for Roche’s Tecentriq/Avastin combo pharmatimes
September 14, 2018
US regulators have extended the review period for Roche’s application to market Tecentriq in combination with Avastin, carboplatin and paclitaxel for first-line...
Third Rock’s Rheos poaches Sanjay Keswani from Roche fiercebiotech
September 07, 2018
Third Rock Ventures’ Rheos Medicines has named former Roche SVP Sanjay Keswani, M.D., as CEO.
Roche to create industry-ready graduates biospectrumasia
September 03, 2018
Through this partnership, the University will recruit biology and chemistry students to join the Roche Academy.
Roche's CEO of the diagnostic division to step down biospectrumasia
August 30, 2018
Michael Heuer, currently Region Head Europe, Middle East, Africa, and Latin America for Roche Diagnostics will assume the ad interim leadership of Roche’s Diagnostics Division and become a member of the Corporate Executive Committee
Affimed lands big, backloaded immunotherapy deal with Genentech, sending its stock into overdrive fiercebiotech
August 29, 2018
Shares in Affimed were up more than 140% in premarket trading.
FDA approves Roche’s cobas EGFR blood test as a companion diagnostic for AZ’s Iressa fiercebiotech
August 28, 2018
The FDA's OK follows companion diagnostic approvals in NSCLC for tyrosine kinase inhibitors Tarceva and Tagrisso. (Roche)
Roche's Alecensa receives 'priority review' designation from CNDA biospectrumasia
August 22, 2018
Alecensa is now approved in over 57 countries around the world as an initial (first-line) treatment for ALK-positive advanced NSCLC, including the US, Europe and Japan
Xolair deemed ‘breakthrough’ therapy for food allergies pharmatimes
August 15, 2018
Roche/Novartis’ Xolair has been awarded breakthrough status in the US for treatment of severe allergic reactions after accidental exposure to foods allergens.
FMI test helps predict response to Roche's drug biospectrumasia
August 08, 2018
The study, demonstrates the potential of bTMB to expand precision oncology approaches for patients with advanced cancers, including metastatic lung cancer.
Roche, Johnson & Johnson pulled into Justice Department probe of alleged terrorist bribes fiercepharma
August 03, 2018
Days after AstraZeneca disclosed that it’s under Justice Department scrutiny for allegedly funding Iraqi terrorism, Johnson & Johnson and Roche also revealed similar inquiries from the agency.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page